The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer.
With evolving technologies and emerging treatment options, this call is focused on defining subgroups of patients with a given diagnosis, understanding the role and improving detection of minimal residual disease (MRD) in hematological malignancies and using this information to guide treatment intervention. LLS has formed a partnership with Celgene to create the first set of such grants that will build the foundation of this new initiative.
1. Official's deadline: June 3rd, 2014. Letter of Intent (LoI): LoIs will summarize the proposed research and indicate which topic is most appropriate. LOIs will be reviewed for responsiveness to the grant outline, and approved (ore rejected) by LLS staff shortly after the time of submission.
2. Full application:Official's deadline: July 15th, 2014.
1- Declaration of interest: IISPV's deadline: May 15, 2014 (europa@iispv.cat). LOI: May 23th, 2014. Full proposal: IISPV's deadline: Application July 9th, 2014.
Work
C/ Dr. Mallafrè Guasch, 4
Edifici modular Hospital Universitari de Tarragona Joan XXIII
43007 Tarragona
Tel./Fax Work977 24 97 72 http://www.iispv.cathttp://www.iispv.cat
Work
C/ Sant Llorenç, 21
Planta baixa de l'edifici 4 de la Facultat de Medicina i Ciències de la Salut
43201 Reus (Tarragona)
Tel./Fax Work977 75 93 96 / 977 75 93 95
Fax977 75 93 93
http://www.iispv.cathttp://www.iispv.cat